Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04263259 · ClinicalTrials.gov registry record · NA

Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification

A NA study of Alcohol; Harmful Use, sponsored by University of New Mexi.

Completed
Registry status
NA
Development phase
31
Enrollment target
2
Study locations

NCT04263259 is a NA study of Alcohol; Harmful Use that has completed, run by University of New Mexi. The registered enrollment target is 31 participants, below the 376-participant average among 9 other Alcohol; Harmful Use trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04263259, a NA study of Alcohol; Harmful Use, has completed, sponsored by University of New Mexi.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
2
Study locations

Study Summary

This study evaluates the efficacy as well as psychological and neurobiological mechanisms of mobile-delivered alcohol attentional bias modification among heavy drinking adults.

Conditions Studied

Interventions

  • BEHAVIORAL Attentional Bias Modification

Study Locations (2)

New Mexico

  • Center on Alcoholism, Substance Abuse, & Addictions - Albuquerque
  • Mind Research Network - Albuquerque

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2020-01-08
Est. Completion 2021-08-14
Phase NA

Sponsor

University of New Mexi

76 total trials

What the Registry Record Tells You About NCT04263259

The ClinicalTrials.gov registry entry for NCT04263259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 9 other Alcohol; Harmful Use trials with a reported enrollment target (92% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol; Harmful Use appearing as the primary indexed condition, and to 1 intervention - of which Attentional Bias Modification is the first listed.

NCT04263259 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT04263259 about?

NCT04263259 is a clinical study titled "Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification". This study evaluates the efficacy as well as psychological and neurobiological mechanisms of mobile-delivered alcohol attentional bias modification among heavy drinking adults.

What is the current status of trial NCT04263259?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2020-01-08. Estimated completion is 2021-08-14.

What conditions does trial NCT04263259 study?

This clinical trial studies the following conditions: Alcohol; Harmful Use.

What interventions are being tested in trial NCT04263259?

The interventions under investigation include: Attentional Bias Modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT04263259?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04263259 being conducted?

This trial has 2 study locations across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol; Harmful Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.